Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:1104-1108

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

(Circulation. 1999;99:1104-1108.)
© 1999 American Heart Association, Inc.


Abstracts of the 39th Annual Conference
on Cardiovascular Disease Epidemiology
and Prevention

Oral Presentations

1 Trends in Severity of Hospitalized Myocardial Infarction: The ARIC Study, 1987-1994.

David C. Goff, George Howard, Chin-Hua Wang, Aaron R. Folsom, Wayne D. Rosamond, Lawton S. Cooper, Lloyd E. Chambless, National Heart, Lung and Blood Institute, Bethesda, MD, University of Minnesota, Minneapolis, MN, University of North Carolina, Chapel Hill, NC, Wake Forest University School of Medicine, Winston-Salem, NC

Declining rates of CHD mortality observed in the US could be due to declining incidence of CHD, declining severity of CHD, and/or improving management of CHD. We examined trends in severity of hospitalized MI to characterize its potential contribution to this decline. Data from the community surveillance component of the ARIC Study were examined for the period 1987 through 1994 for all hospitalizations that met criteria for definite or probable incident MI (N = 4903). Hemodynamic, electrocardiographic and enzymatic indicators of severity of MI and diagnostic categories were examined. Temporal trends in these severity indicators were tested with adjustment for age, sex, race, and community (and use of thrombolytics for peak CK). No significant temporal change in the proportion having SBP < 100 mm Hg or an abnormal pulse was noted. The proportion with ST elevation on the initial ECG increased 10% per year (p<0.001), and the proportion with a diagnostic (or evolving diagnostic) ECG abnormality increased 4% per year (p<0.01); whereas, the proportion that developed a new Q-wave during the hospitalization remained unchanged. The mean peak CK declined 5% per year (p<0.001), the proportion with abnormal enzymes declined 10% per year (p<0.001), and the proportion that met criteria for definite (versus probable) . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
E. J. Benjamin, S. C. Smith Jr, R. S. Cooper, M. N. Hill, and R. V. Luepker
Task Force #1--magnitude of the prevention problem: opportunities and challenges
J. Am. Coll. Cardiol., August 21, 2002; 40(4): 588 - 603.
[Full Text] [PDF]


Home page
Eur Heart JHome page
R.V. Luepker
Cholesterol reduction: What can we afford?
Eur. Heart J., May 1, 2001; 22(9): 720 - 721.
[PDF]